- Home
- ACIU vs BPRN Comparison
ACIU vs BPRN Comparison
Compare ACIU & BPRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- BPRN
- Stock Information
- Founded
- ACIU 2003
- BPRN 2007
- Country
- ACIU Switzerland
- BPRN United States
- Employees
- ACIU N/A
- BPRN N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- BPRN Major Banks
- Sector
- ACIU Health Care
- BPRN Finance
- Exchange
- ACIU Nasdaq
- BPRN Nasdaq
- Market Cap
- ACIU 247.4M
- BPRN 210.4M
- IPO Year
- ACIU 2016
- BPRN N/A
- Fundamental
- Price
- ACIU $1.77
- BPRN $28.85
- Analyst Decision
- ACIU Strong Buy
- BPRN Strong Buy
- Analyst Count
- ACIU 2
- BPRN 1
- Target Price
- ACIU $12.00
- BPRN $35.00
- AVG Volume (30 Days)
- ACIU 185.3K
- BPRN 6.1K
- Earning Date
- ACIU 05-12-2025
- BPRN 04-24-2025
- Dividend Yield
- ACIU N/A
- BPRN 4.16%
- EPS Growth
- ACIU N/A
- BPRN N/A
- EPS
- ACIU N/A
- BPRN 1.55
- Revenue
- ACIU $30,136,397.00
- BPRN $69,578,000.00
- Revenue This Year
- ACIU N/A
- BPRN $13.44
- Revenue Next Year
- ACIU $680.74
- BPRN $16.24
- P/E Ratio
- ACIU N/A
- BPRN $18.61
- Revenue Growth
- ACIU 84.51
- BPRN 0.35
- 52 Week Low
- ACIU $1.77
- BPRN $28.85
- 52 Week High
- ACIU $4.98
- BPRN $39.35
- Technical
- Relative Strength Index (RSI)
- ACIU 25.49
- BPRN 34.28
- Support Level
- ACIU $1.77
- BPRN $30.50
- Resistance Level
- ACIU $2.05
- BPRN $31.00
- Average True Range (ATR)
- ACIU 0.12
- BPRN 0.55
- MACD
- ACIU -0.02
- BPRN -0.05
- Stochastic Oscillator
- ACIU 0.00
- BPRN 0.00
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About BPRN Princeton Bancorp Inc. (PA)
Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.